Commodore Capital LP’s Cogent Biosciences Inc Position
Does Commodore Capital LP own Cogent Biosciences Inc (COGT)? Yes — 2.89M shares worth $111M (+6.43% of its 13F portfolio) as of Q1 2026, up from 2.20M shares the prior filed quarter.
Position Value
$111M
Q1 2026
Shares
2.89M
% of Portfolio
+6.43%
Quarters Held
22
currently held
Position History COGT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.89M | $111M | +6.43% |
| Q4 2025 | 2.20M | $78M | +5.19% |
| Q3 2025 | 7.25M | $104M | +5.08% |
| Q2 2025 | 2.31M | $17M | +1.17% |
| Q1 2025 | 8.89M | $53M | +3.93% |
| Q4 2024 | 6.88M | $54M | +3.93% |
| Q3 2024 | 7.54M | $81M | +5.09% |
| Q2 2024 | 9.74M | $82M | +5.60% |
| Q1 2024 | 6.42M | $43M | +2.89% |
| Q4 2023 | 5.57M | $33M | +2.86% |
| Q3 2023 | 5.57M | $54M | +6.34% |
| Q2 2023 | 5.57M | $66M | +7.41% |
| Q1 2023 | 4.77M | $51M | +7.84% |
| Q4 2022 | 4.32M | $49,939 | +7.53% |
| Q3 2022 | 4.32M | $64M | +10.36% |
| Q2 2022 | 4.94M | $45M | +9.43% |
| Q1 2022 | 3.50M | $26M | +5.86% |
| Q4 2021 | 2.28M | $20M | +4.53% |
| Q3 2021 | 1.91M | $16M | +4.24% |
| Q2 2021 | 1.37M | $11M | +3.82% |
| Q1 2021 | 1.27M | $11M | +4.39% |
| Q4 2020 | 760.0K | $9M | +4.64% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of COGT.